Grenzach-Wyhlen, Germany

Georg Friedrich Melchers

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: 4-Antibody Ag. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Georg Friedrich Melchers. Retrieved from https://idiyas.com/inventor/georg-friedrich-melchers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Georg Friedrich Melchers: Innovator in Genetic Engineering

Introduction

Georg Friedrich Melchers is a notable inventor based in Grenzach-Wyhlen, Germany. He has made significant contributions to the fields of genetic engineering and antibody production. His work focuses on the generation of genetically modified vertebrate precursor lymphocytes, which have the potential to differentiate into more mature lymphoid lineage cells.

Latest Patents

Melchers holds a patent for a method titled "Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins." This invention relates to the production of heterologous antibodies or binding proteins, showcasing his innovative approach to genetic engineering.

Career Highlights

Throughout his career, Melchers has been associated with 4-antibody AG, where he has furthered his research and development in antibody production. His expertise in genetic engineering has positioned him as a key figure in the industry.

Collaborations

Melchers has worked alongside Ulf Grawunder, contributing to advancements in their field. Their collaboration has been instrumental in pushing the boundaries of genetic engineering and antibody production.

Conclusion

Georg Friedrich Melchers is a pioneering inventor whose work in genetic engineering has the potential to revolutionize antibody production. His contributions continue to impact the scientific community and the development of innovative solutions in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…